30-day FRN

43258

Federal Register / Vol. 86, No. 149 / Friday, August 6, 2021 / Notices

through the use of appropriate
automated collection techniques of
other forms of information technology,
e.g., permitting electronic submission of
responses.
Title: 0917–0014, ‘‘Indian Health
Service Loan Repayment Program.’’
Type of Information Collection
Request: Three year extension approval
of this information collection.
OMB Control Number: 0917–0014.
Forms: Educational and Professional
Background, Financial Information, and
General Applicant Information (i.e., all
forms are part of the LRP application).
The LRP application is available in an
electronically fillable and fileable
format.
Need and Use of Information
Collection: The IHS LRP identifies
health professionals with pre-existing
financial obligations for education
expenses that meet program criteria and
who are qualified and willing to serve

at, often remote, IHS health care
facilities. Under the program, eligible
health professionals sign a contract
through which the IHS agrees to repay
part or all of their indebtedness in
exchange for an initial two-year service
commitment to practice fulltime at an
eligible Indian health program. This
program is necessary to augment the
critically low health professional staff at
IHS health care facilities.
Eligible health professionals wishing
to have their health education loans
repaid may apply to the IHS LRP. A
two-year contract obligation is signed by
both parties, and the individual agrees
to work at an eligible Indian health
program location and provide health
services to American Indian and Alaska
Native individuals.
The information collected via the online application from individuals is
analyzed and a score is given to each
applicant. This score will determine

which applicants will be awarded each
fiscal year. The administrative scoring
system assigns a score to the geographic
location according to vacancy rates for
that fiscal year and also considers
whether the location is in an isolated
area. When an applicant accepts
employment at a location, the applicant
in turn ‘‘picks-up’’ the score of that
location.
Status of the Proposed Information
Collection: Renewal of a current
collection.
Affected Public: Individuals and
households.
Type of Respondents: Individuals.
The table below provides: Types of
data collection instruments, estimated
number of respondents, Number of
responses per respondent, annual
number of responses, Average burden
hour per response, and Total annual
burden hour(s).

ESTIMATED BURDEN HOURS
Data collection instrument(s)

Number of
respondents

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total annual
responses
(in hours)

LRP Application ...............................................................................................
LRP Application (3 forms in total)

1,999

1

1.5

2,998.5

There are no Capital Costs, Operating
Costs, and/or Maintenance Costs to
report.
Elizabeth A. Fowler,
Acting Director, Indian Health Service.
[FR Doc. 2021–16837 Filed 8–5–21; 8:45 am]
BILLING CODE 4165–16–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Post-Award
Reporting Requirements Including
Research Performance Progress
Report Collection (Office of the
Director)
National Institutes of Health,
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured

jbell on DSKJLSW7X2PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

19:29 Aug 05, 2021

Jkt 253001

of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Ms. Mikia P.
Currie, Program Analyst, Office of
Policy for Extramural Research
Administration, 6705 Rockledge Drive,
Suite 350, Bethesda, Maryland 20892, or
call a non-toll-free number 301–435–
0941 or Email your request, including
your address to
ProjectClearanceBranch@mail.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on April 12, 2021, pages

PO 00000

Frm 00100

Fmt 4703

Sfmt 4703

18994–18995 (86 FR 18994) and
allowed 60 days for public comment. No
public comments were received. The
purpose of this notice is to allow an
additional 30 days for public comment.
The Office of the Director (OD) Office of
Policy and Extramural Research
Administration (OPERA), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Public Health
Service (PHS) Post-award Reporting
Requirements Including Research
Performance Progress Report Collection,
Revision, OMB 0925–0002, Expiration
Date 2/28/2023, Office of the Director
(OD), National Institutes of Health
(NIH).
Need and Use of Information
Collection: This collection is being
revised to omit the Inclusion Enrollment

E:\FR\FM\06AUN1.SGM

06AUN1

43259

Federal Register / Vol. 86, No. 149 / Friday, August 6, 2021 / Notices
Report form, which is being converted
to a Common form to include the
Department of Defense (DoD). The
Inclusion Enrollment Report is used for
all applications involving NIH-defined
clinical research. This form is used to
report both planned and cumulative (or
actual) enrollment, and describes the
sex/gender, race, and ethnicity of the
study participants. Starting in January
2022, NIH will require will applicants
and recipients to provide their Unique
Entity Identifier (UEI) instead of the
Data Universal Number System (DUNS)
number. Also, the application forms
will be updated to align with the
Grants.gov updated Country and State
lists. NIH also anticipates adding an
optional field to the end of our forms
and applications to get a more accurate
assessment of the time it takes our
applicants to complete the various
forms and applications. The RPPR is
required to be used by all NIH, Food
and Drug Administration, Centers for
Disease Control and Prevention, and
Agency for Healthcare Research and
Quality (AHRQ) grantees. Interim
progress reports are required to continue
support of a PHS grant for each budget
year within a competitive segment. The
phased transition to the RPPR required

trials are complex and challenging
research activities. Oversight systems
and tools are critical for NIH to ensure
participant safety, data integrity, and
accountability of the use of public
funds. NIH has been engaged in a multiyear effort to examine how clinical trials
are supported and the level of oversight
needed. The collection of more
structured information in the PHS
applications and pre-award reporting
requirements as well as continued
monitoring and update during the postaward reporting requirements will
facilitate NIH’s oversight of clinical
trials. In addition, some of the data
reported in the RPPR will ultimately be
accessible to investigators to update
certain sections of forms when
registering or reporting their trials with
ClinicalTrials.gov. Frequency of
response: Applicants may submit
applications for published receipt dates.
For NRSA awards, fellowships are
activated, and trainees appointed.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
532,249.

the maintenance of dual reporting
processes for a period of time.
Continued use of the PHS Noncompeting Continuation Progress Report
(PHS 2590), exists for a small group of
grantees. This collection also includes
other PHS post-award reporting
requirements: PHS 416–7 NRSA
Termination Notice, PHS 2271
Statement of Appointment, 6031–1
NRSA Annual Payback Activities
Certification, HHS 568 Final Invention
Statement and Certification, iEdison,
and PHS 3734 Statement Relinquishing
Interests and Rights in a PHS Research
Grant. The PHS 416–7, 2271, and 6031–
1 is used by NRSA recipients to activate,
terminate, and provide for payback of a
NRSA. Closeout of an award requires a
Final Invention Statement (HHS 568)
and Final Progress Report. iEdison
allows grantees and Federal agencies to
meet statutory requirements for
reporting inventions and patents. The
PHS 3734 serves as the official record of
grantee relinquishment of a PHS award
when an award is transferred from one
grantee institution to another. Pre-award
reporting requirements are
simultaneously consolidated under
0925–0001 and the changes to the
collection here are related. Clinical

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Information collection forms

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total annual
burden hours

Reporting
PHS 416–7 ......................................................................................................
PHS 6031–1 ....................................................................................................
PHS 568 ..........................................................................................................
iEdison .............................................................................................................
PHS 2271 ........................................................................................................
PHS 2590 ........................................................................................................
RPPR—Core Data ...........................................................................................
Biosketch (Part of RPPR) ................................................................................
Data Tables (Part of RPPR) ............................................................................
Trainee Diversity Report (Part of RPPR) ........................................................
PHS Human Subjects and Clinical Trial Information (Part of RPPR, includes
inclusion enrollment report) ..........................................................................
Publication Reporting .......................................................................................
Final RPPR—Core Data ..................................................................................
Data Tables (Part of Final RPPR) ...................................................................
Trainee Diversity Report (Part of Final RPPR) ...............................................
PHS Human Subjects and Clinical Trial Information (Part of RPPR, includes
inclusion enrollment report)) ........................................................................
PHS 374 ..........................................................................................................

12,580
1,778
11,180
5,697
22,035
243
32,098
2,544
758
480

1
1
1
1
1
1
1
1
1
1

30/60
20/60
5/60
15/60
15/60
18
8
2
4
15/60

6,290
593
932
1,424
5,509
4,374
256,784
5,088
3,032
120

6,420
97,023
18,000
758
480

1
3
1
1
1

4
5/60
10
4
15/60

25,680
24,256
180,000
3,032
120

3,600
479

1
1

4
30/60

14,400
240

Reporting Burden Total ............................................................................

........................

........................

........................

531,874

jbell on DSKJLSW7X2PROD with NOTICES

Recordkeeping
SBIR/STTR Life Cycle Certification .................................................................

1,500

1

15/60

375

Grand Total ...............................................................................................

217,653

411,699

........................

532,249

VerDate Sep<11>2014

19:29 Aug 05, 2021

Jkt 253001

PO 00000

Frm 00101

Fmt 4703

Sfmt 4703

E:\FR\FM\06AUN1.SGM

06AUN1

43260

Federal Register / Vol. 86, No. 149 / Friday, August 6, 2021 / Notices

Dated: July 30, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

[FR Doc. 2021–16849 Filed 8–5–21; 8:45 am]

National Center for Advancing
Translational Sciences; Notice of
Closed Meeting

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Insulin
Resistance and Alzheimer’s Disease
pathology.
Date: September 3, 2021.
Time: 1:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Maurizio Grimaldi, MD,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, 7201 Wisconsin
Avenue, Gateway Building, Suite 2W200,
Bethesda, MD 20892, 301–496–9374,
grimaldim2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 2, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
jbell on DSKJLSW7X2PROD with NOTICES

[FR Doc. 2021–16803 Filed 8–5–21; 8:45 am]
BILLING CODE 4140–01–P

National Institutes of Health

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Rare Diseases.
Date: September 14, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Advancing
Translational Sciences, National Institutes of
Health, 6701 Democracy Boulevard, Room
1037, Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Alumit Ishai, Ph.D.,
Scientific Review Officer, Office of Grants
Management and Scientific Review, National
Center for Advancing Translational Sciences,
National Institutes of Health, 6701
Democracy Boulevard, Room 1037, Bethesda,
MD 20817, 301–827–5819, alumit.ishai@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16866 Filed 8–5–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

19:29 Aug 05, 2021

Jkt 253001

PO 00000

Frm 00102

Fmt 4703

Sfmt 4703

Name of Committee: National Eye Institute
Special Emphasis Panel; Request for
Proposals 75N98021R00006: Development,
Statistical Design, Monitoring and
Coordination of Vision Clinical Trials and
Epidemiology Research.
Date: August 30, 2021.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Eye Institute, National
Institutes of Health, 6700B Rockledge Drive,
Suite 3400, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Brian Hoshaw, Ph.D.,
Designated Federal Official, Division of
Extramural Research, National Eye Institute,
National Institutes of Health, 6700B
Rockledge Drive, Suite 3400, Bethesda, MD
20892, 301–451–2020, hoshawb@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: August 3, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–16863 Filed 8–5–21; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR 6277–N–01]

Fair Market Rents for the Housing
Choice Voucher Program, Moderate
Rehabilitation Single Room Occupancy
Program, and Other Programs Fiscal
Year 2022
Office of the Assistant
Secretary for Policy Development and
Research, Housing and Urban
Development (HUD).
ACTION: Notice of Fiscal Year (FY) 2022
Fair Market Rents (FMRs).
AGENCY:

Section 8(c)(1) of the United
States Housing Act of 1937 (USHA), as
amended by the Housing Opportunities
Through Modernization Act of 2016
(HOTMA), requires the Secretary to
publish FMRs not less than annually,
adjusted to be effective on October 1 of
each year. This notice describes the

SUMMARY:

National Eye Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.

VerDate Sep<11>2014

The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

E:\FR\FM\06AUN1.SGM

06AUN1